PHILADELPHIA, July 10, 2008 (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies, today announced the appointment of A. William (Bill) Newbould to the newly created position of Vice President, Investor Relations. Reporting directly to Eurand’s Chief Executive Officer Gearoid Faherty, Newbould will be responsible for developing and implementing the Company’s investor relations program. He will be based in Eurand’s Yardley, Pennsylvania, office.
